Neil Almstead's most recent trade in PTC Therapeutics Inc was a trade of 1,578 Common Stock done at an average price of $50.1 . Disclosure was reported to the exchange on Feb. 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 50.12 per share. | 19 Feb 2025 | 1,578 | 100,353 (0%) | 0% | 50.1 | 79,096 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 50.10 per share. | 19 Feb 2025 | 1,300 | 101,931 (0%) | 0% | 50.1 | 65,125 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 50.09 per share. | 19 Feb 2025 | 34 | 5,941 (0%) | 0% | 50.1 | 1,703 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 50.12 per share. | 19 Feb 2025 | 34 | 5,907 (0%) | 0% | 50.1 | 1,704 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 44.50 per share. | 07 Jan 2025 | 1,552 | 103,231 (0%) | 0% | 44.5 | 69,064 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 45.34 per share. | 07 Jan 2025 | 1,265 | 104,783 (0%) | 0% | 45.3 | 57,355 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 44.50 per share. | 07 Jan 2025 | 107 | 5,975 (0%) | 0% | 44.5 | 4,762 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 45.35 per share. | 07 Jan 2025 | 55 | 6,082 (0%) | 0% | 45.3 | 2,494 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 47,500 | 47,500 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 19,000 | 106,048 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 715 | 6,137 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Almstead Neil | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 66,956 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Almstead Neil | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.00 per share. | 02 Dec 2024 | 66,956 | 153,158 (0%) | 0% | 51 | 3,414,756 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 51.97 per share. | 02 Dec 2024 | 58,345 | 94,813 (0%) | 0% | 52.0 | 3,032,190 | Common Stock |
| PTC Therapeutics Inc | Almstead Neil | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 52.72 per share. | 02 Dec 2024 | 8,611 | 86,202 (0%) | 0% | 52.7 | 453,972 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.00 per share. | 02 Dec 2024 | 2,594 | 88,796 (0%) | 0% | 51 | 132,294 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 2,594 | 66,956 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Almstead Neil | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 51.85 per share. | 02 Dec 2024 | 2,328 | 86,468 (0%) | 0% | 51.9 | 120,707 | Common Stock |
| PTC Therapeutics Inc | Almstead Neil | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.00 per share. | 02 Dec 2024 | 2,060 | 6,636 (0%) | 0% | 51 | 105,060 | Common Stock |
| PTC Therapeutics Inc | Almstead Neil | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 2,060 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 51.85 per share. | 02 Dec 2024 | 1,783 | 4,853 (0%) | 0% | 51.9 | 92,449 | Common Stock |
| PTC Therapeutics Inc | Almstead Neil | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 52.76 per share. | 02 Dec 2024 | 277 | 4,576 (0%) | 0% | 52.8 | 14,615 | Common Stock |
| PTC Therapeutics Inc | Almstead Neil | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 52.73 per share. | 02 Dec 2024 | 266 | 86,202 (0%) | 0% | 52.7 | 14,026 | Common Stock |
| PTC Therapeutics Inc | Almstead Neil | CHIEF TECHNICAL OPS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 47,500 | 47,500 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 19,000 | 80,202 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 6,000 | 86,202 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 870 | 4,576 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 27.25 per share. | 30 Jan 2024 | 618 | 61,202 (0%) | 0% | 27.3 | 16,841 | Common Stock |
| PTC Therapeutics Inc | Almstead Neil | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 27.25 per share. | 30 Jan 2024 | 28 | 3,706 (0%) | 0% | 27.3 | 763 | Common Stock |
| PTC Therapeutics Inc | Almstead Neil | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 29.02 per share. | 08 Jan 2024 | 1,521 | 61,820 (0%) | 0% | 29.0 | 44,132 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 28.64 per share. | 08 Jan 2024 | 1,236 | 63,341 (0%) | 0% | 28.6 | 35,399 | Common Stock |
| PTC Therapeutics Inc | Almstead Neil | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 29.01 per share. | 08 Jan 2024 | 100 | 3,734 (0%) | 0% | 29.0 | 2,901 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 28.64 per share. | 08 Jan 2024 | 53 | 3,834 (0%) | 0% | 28.6 | 1,518 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 45.63 per share. | 31 Jan 2023 | 630 | 63,949 (0%) | 0% | 45.6 | 28,746 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 45.64 per share. | 31 Jan 2023 | 28 | 3,259 (0%) | 0% | 45.6 | 1,278 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 47.45 per share. | 24 Jan 2023 | 44 | 3,287 (0%) | 0% | 47.5 | 2,088 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 42.93 per share. | 10 Jan 2023 | 473 | 64,962 (0%) | 0% | 42.9 | 20,307 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 44.36 per share. | 10 Jan 2023 | 383 | 64,579 (0%) | 0% | 44.4 | 16,990 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 42.93 per share. | 10 Jan 2023 | 27 | 3,358 (0%) | 0% | 42.9 | 1,159 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 44.37 per share. | 10 Jan 2023 | 27 | 3,331 (0%) | 0% | 44.4 | 1,198 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 41.66 per share. | 09 Jan 2023 | 716 | 65,435 (0%) | 0% | 41.7 | 29,826 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 41.65 per share. | 09 Jan 2023 | 43 | 3,385 (0%) | 0% | 41.7 | 1,791 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 36,250 | 36,250 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 17,000 | 66,151 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 710 | 3,428 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 01 Feb 2022 | 605 | 48,853 (0%) | 0% | 40.0 | 24,201 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 01 Feb 2022 | 27 | 2,420 (0%) | 0% | 40 | 1,080 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Sale of securities on an exchange or to another person at price $ 39.33 per share. | 25 Jan 2022 | 43 | 2,447 (0%) | 0% | 39.3 | 1,691 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 54,000 | 54,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 14,400 | 49,458 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 780 | 2,490 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Sale of securities on an exchange or to another person at price $ 38.53 per share. | 07 Jan 2022 | 756 | 35,058 (0%) | 0% | 38.5 | 29,125 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Sale of securities on an exchange or to another person at price $ 38.53 per share. | 07 Jan 2022 | 45 | 1,710 (0%) | 0% | 38.5 | 1,734 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Sale of securities on an exchange or to another person at price $ 41.16 per share. | 04 Jan 2022 | 64 | 1,755 (0%) | 0% | 41.2 | 2,634 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Sale of securities on an exchange or to another person at price $ 56.96 per share. | 01 Feb 2021 | 973 | 35,814 (0%) | 0% | 57.0 | 55,418 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Sale of securities on an exchange or to another person at price $ 56.96 per share. | 01 Feb 2021 | 28 | 1,819 (0%) | 0% | 57.0 | 1,595 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Sale of securities on an exchange or to another person at price $ 63.25 per share. | 25 Jan 2021 | 497 | 1,891 (0%) | 0% | 63.2 | 31,435 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Sale of securities on an exchange or to another person at price $ 62.05 per share. | 25 Jan 2021 | 44 | 1,847 (0%) | 0% | 62.0 | 2,730 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.05 per share. | 08 Jan 2021 | 1,300 | 3,688 (0%) | 0% | 27.1 | 35,165 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Sale of securities on an exchange or to another person at price $ 69.00 per share. | 08 Jan 2021 | 1,300 | 2,388 (0%) | 0% | 69 | 89,700 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2021 | 1,300 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2021 | 59,500 | 59,500 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2021 | 10,200 | 36,787 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2021 | 600 | 2,388 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Sale of securities on an exchange or to another person at price $ 62.37 per share. | 05 Jan 2021 | 502 | 26,587 (0%) | 0% | 62.4 | 31,310 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Sale of securities on an exchange or to another person at price $ 62.37 per share. | 05 Jan 2021 | 68 | 1,788 (0%) | 0% | 62.4 | 4,241 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Sale of securities on an exchange or to another person at price $ 62.38 per share. | 05 Jan 2021 | 56 | 1,856 (0%) | 0% | 62.4 | 3,493 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.01 per share. | 04 Jan 2021 | 48,125 | 75,214 (0%) | 0% | 18.0 | 866,731 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 48,125 | 17,500 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Sale of securities on an exchange or to another person at price $ 60.57 per share. | 04 Jan 2021 | 47,936 | 27,278 (0%) | 0% | 60.6 | 2,903,723 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.05 per share. | 04 Jan 2021 | 32,771 | 59,860 (0%) | 0% | 27.1 | 886,456 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 32,771 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Sale of securities on an exchange or to another person at price $ 60.58 per share. | 04 Jan 2021 | 32,571 | 27,289 (0%) | 0% | 60.6 | 1,973,021 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.05 per share. | 04 Jan 2021 | 7,229 | 34,318 (0%) | 0% | 27.0 | 195,544 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Sale of securities on an exchange or to another person at price $ 60.59 per share. | 04 Jan 2021 | 7,229 | 27,089 (0%) | 0% | 60.6 | 438,012 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 7,229 | 32,771 | - | - | Stock Option (Right To Buy) | |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.23 per share. | 04 Jan 2021 | 5,715 | 32,804 (0%) | 0% | 11.2 | 64,179 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 5,715 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Sale of securities on an exchange or to another person at price $ 60.56 per share. | 04 Jan 2021 | 5,615 | 27,189 (0%) | 0% | 60.6 | 340,044 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Sale of securities on an exchange or to another person at price $ 60.59 per share. | 04 Jan 2021 | 4,188 | 27,089 (0%) | 0% | 60.6 | 253,743 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.01 per share. | 04 Jan 2021 | 4,188 | 31,277 (0%) | 0% | 18.0 | 75,426 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 4,188 | 65,812 | - | - | Stock Option (Right To Buy) | |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.23 per share. | 04 Jan 2021 | 3,035 | 30,124 (0%) | 0% | 11.2 | 34,083 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 3,035 | 7,903 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Sale of securities on an exchange or to another person at price $ 60.56 per share. | 04 Jan 2021 | 2,935 | 27,189 (0%) | 0% | 60.6 | 177,741 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Sale of securities on an exchange or to another person at price $ 60.54 per share. | 04 Jan 2021 | 2,188 | 27,089 (0%) | 0% | 60.5 | 132,466 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.23 per share. | 04 Jan 2021 | 2,188 | 29,277 (0%) | 0% | 11.2 | 24,571 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 2,188 | 5,715 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Sale of securities on an exchange or to another person at price $ 60.65 per share. | 04 Jan 2021 | 600 | 1,912 (0%) | 0% | 60.7 | 36,390 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.85 per share. | 04 Jan 2021 | 600 | 2,512 (0%) | 0% | 10.9 | 6,510 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 600 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Sale of securities on an exchange or to another person at price $ 61.24 per share. | 04 Jan 2021 | 200 | 27,089 (0%) | 0% | 61.2 | 12,249 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Sale of securities on an exchange or to another person at price $ 61.24 per share. | 04 Jan 2021 | 189 | 27,089 (0%) | 0% | 61.2 | 11,574 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Sale of securities on an exchange or to another person at price $ 60.61 per share. | 04 Jan 2021 | 187 | 27,089 (0%) | 0% | 60.6 | 11,334 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.01 per share. | 04 Jan 2021 | 187 | 27,276 (0%) | 0% | 18.0 | 3,368 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 187 | 65,625 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Sale of securities on an exchange or to another person at price $ 61.24 per share. | 04 Jan 2021 | 100 | 27,089 (0%) | 0% | 61.2 | 6,124 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Sale of securities on an exchange or to another person at price $ 61.36 per share. | 04 Jan 2021 | 100 | 27,089 (0%) | 0% | 61.4 | 6,136 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.23 per share. | 04 Nov 2020 | 21,875 | 48,964 (0%) | 0% | 11.2 | 245,656 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 04 Nov 2020 | 21,875 | 27,089 (0%) | 0% | 60 | 1,312,500 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | Chief Technical Ops Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2020 | 21,875 | 10,938 | - | - | Stock Option (Right to Buy) |